Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
ObjectivePatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.DesignWe analysed the faecal micr...
Saved in:
Published in | Gut Vol. 69; no. 1; pp. 92 - 102 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group LTD
01.01.2020
BMJ Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0017-5749 1468-3288 1468-3288 |
DOI | 10.1136/gutjnl-2018-317791 |
Cover
Loading…
Abstract | ObjectivePatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.DesignWe analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively.ResultsWe found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of Exophiala and a decreased proportion of Saccharomyces cerevisiae. Compared with patients with IBD and healthy subjects, the gut microbiota of patients with PSC exhibited a strong disruption in bacteria-fungi correlation network, suggesting an alteration in the interkingdom crosstalk.ConclusionThis study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC. |
---|---|
AbstractList | Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.
We analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively.
We found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of
and a decreased proportion of
. Compared with patients with IBD and healthy subjects, the gut microbiota of patients with PSC exhibited a strong disruption in bacteria-fungi correlation network, suggesting an alteration in the interkingdom crosstalk.
This study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC. Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC. ObjectivePatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.DesignWe analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively.ResultsWe found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of Exophiala and a decreased proportion of Saccharomyces cerevisiae. Compared with patients with IBD and healthy subjects, the gut microbiota of patients with PSC exhibited a strong disruption in bacteria-fungi correlation network, suggesting an alteration in the interkingdom crosstalk.ConclusionThis study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC. Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.OBJECTIVEPatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC.We analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively.DESIGNWe analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively.We found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of Exophiala and a decreased proportion of Saccharomyces cerevisiae. Compared with patients with IBD and healthy subjects, the gut microbiota of patients with PSC exhibited a strong disruption in bacteria-fungi correlation network, suggesting an alteration in the interkingdom crosstalk.RESULTSWe found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of Exophiala and a decreased proportion of Saccharomyces cerevisiae. Compared with patients with IBD and healthy subjects, the gut microbiota of patients with PSC exhibited a strong disruption in bacteria-fungi correlation network, suggesting an alteration in the interkingdom crosstalk.This study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC.CONCLUSIONThis study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC. |
Author | Sokol, Harry Housset, Chantal Jegou, Sarah Ben Belkacem, Karima Kemgang, Astrid Corpechot, Christophe Chazouillères, Olivier Lemoinne, Sara Straube, Marjolène |
Author_xml | – sequence: 1 givenname: Sara surname: Lemoinne fullname: Lemoinne, Sara email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 2 givenname: Astrid surname: Kemgang fullname: Kemgang, Astrid email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 3 givenname: Karima surname: Ben Belkacem fullname: Ben Belkacem, Karima email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 4 givenname: Marjolène surname: Straube fullname: Straube, Marjolène email: harry.sokol@aphp.fr organization: Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 5 givenname: Sarah surname: Jegou fullname: Jegou, Sarah email: harry.sokol@aphp.fr organization: Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 6 givenname: Christophe surname: Corpechot fullname: Corpechot, Christophe email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 8 givenname: Olivier surname: Chazouillères fullname: Chazouillères, Olivier email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 9 givenname: Chantal orcidid: 0000-0001-6469-0651 surname: Housset fullname: Housset, Chantal email: harry.sokol@aphp.fr organization: Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France – sequence: 10 givenname: Harry orcidid: 0000-0002-2914-1822 surname: Sokol fullname: Sokol, Harry email: harry.sokol@aphp.fr organization: UMR Micalis, AgroParisTech, INRA, Jouy-en-Josas, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31003979$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-02116096$$DView record in HAL |
BookMark | eNqNkUtv1DAUhS1URKeFP8ACWWJDFym-TuLHsqooRRqpG1hbjuPMeJTYg-1Q9d_jKNMuukCsLF9959zHuUBnPniL0Ecg1wA1-7qb88GPFSUgqho4l_AGbaBh5UeFOEMbQoBXLW_kObpI6UAIEULCO3ReAyG15HKD-rvZ7xw-6pidcUedLXYe573F_VPqXEgu4TDg0gpPzsRQSlkvSEGd9TnhR5f3-BjdpOMTTma0sYj8Dpt9GHXxzi69R28HPSb74fReol93337e3lfbh-8_bm-2Vdc0PFeGUGM4Z72gpuuolK0ogxpglLUdpZY1TA5agqS8031LjQRrBlb3YpCt1bq-RFer716P6jSSCtqp-5utWmqEAjAi2R8o7JeVPcbwe7Ypq8klY8cysw1zUrSgspGM8oJ-foUewhx92UTRuhGUti1bDD-dqLmbbP_S__nWBRArUM6YUrSDMi6XKwafo3ajAqKWWNUaq1piVWusRUpfSZ_d_ymqVlE3Hf6H_wv2NrVi |
CitedBy_id | crossref_primary_10_1016_S2666_5247_22_00203_8 crossref_primary_10_1016_j_fmre_2024_09_007 crossref_primary_10_1152_physiol_00005_2020 crossref_primary_10_1155_2023_5431615 crossref_primary_10_3389_fmicb_2023_1149311 crossref_primary_10_1053_j_gastro_2020_12_058 crossref_primary_10_3390_ijms22136975 crossref_primary_10_7717_peerj_14260 crossref_primary_10_1186_s10020_024_00830_x crossref_primary_10_3389_fmed_2021_725390 crossref_primary_10_1097_TP_0000000000004563 crossref_primary_10_1038_s41467_023_36479_z crossref_primary_10_1080_19490976_2020_1830693 crossref_primary_10_1111_liv_14153 crossref_primary_10_3390_nu15030760 crossref_primary_10_3390_biomedicines10061288 crossref_primary_10_1016_j_ebiom_2020_102950 crossref_primary_10_1002_lt_25908 crossref_primary_10_1016_j_eng_2022_12_012 crossref_primary_10_1016_j_jhep_2022_12_006 crossref_primary_10_1080_19490976_2023_2265028 crossref_primary_10_1002_hep_32771 crossref_primary_10_1016_j_phytochem_2024_114162 crossref_primary_10_1515_med_2022_0481 crossref_primary_10_3389_fmicb_2021_724980 crossref_primary_10_1093_ismeco_ycae057 crossref_primary_10_1016_j_ijbiomac_2022_02_056 crossref_primary_10_1111_myc_13238 crossref_primary_10_1186_s12876_021_01974_4 crossref_primary_10_7554_eLife_99282 crossref_primary_10_3389_fmed_2020_00117 crossref_primary_10_1016_j_schres_2022_10_011 crossref_primary_10_3748_wjg_v26_i21_2768 crossref_primary_10_3389_fphys_2021_715536 crossref_primary_10_3390_jof7090748 crossref_primary_10_3390_gastroent14040041 crossref_primary_10_1080_19490976_2023_2211922 crossref_primary_10_1002_hep_31311 crossref_primary_10_1093_femsre_fuaa060 crossref_primary_10_1093_ibd_izad203 crossref_primary_10_1093_ibd_izad289 crossref_primary_10_3389_fcimb_2023_1129043 crossref_primary_10_1080_17474124_2022_2031979 crossref_primary_10_3390_foods13071124 crossref_primary_10_1038_s41385_021_00429_z crossref_primary_10_1111_1751_7915_13970 crossref_primary_10_3389_fimmu_2022_791152 crossref_primary_10_3389_fphys_2021_699253 crossref_primary_10_1016_j_medmic_2020_100008 crossref_primary_10_1172_JCI174218 crossref_primary_10_1016_j_rhum_2022_03_007 crossref_primary_10_1128_spectrum_00615_21 crossref_primary_10_3390_ht9030017 crossref_primary_10_1097_HEP_0000000000000506 crossref_primary_10_1128_spectrum_02360_23 crossref_primary_10_3389_fmmed_2022_914505 crossref_primary_10_1002_hep_32773 crossref_primary_10_1016_j_jhep_2021_08_003 crossref_primary_10_1007_s11046_023_00743_z crossref_primary_10_1097_MOG_0000000000000910 crossref_primary_10_3390_microorganisms9081752 crossref_primary_10_3389_fimmu_2021_728723 crossref_primary_10_1038_s41598_024_51903_0 crossref_primary_10_54457_DR_202302003 crossref_primary_10_3389_fmicb_2022_953300 crossref_primary_10_3390_jcm11030649 crossref_primary_10_1111_tri_13692 crossref_primary_10_1111_jam_15620 crossref_primary_10_1038_s42003_021_01820_z crossref_primary_10_1172_JCI155786 crossref_primary_10_1111_apt_17251 crossref_primary_10_1038_s41575_022_00690_y crossref_primary_10_3389_fnut_2023_1089909 crossref_primary_10_1515_mr_2024_0029 crossref_primary_10_1186_s12879_021_06270_w crossref_primary_10_3389_fimmu_2023_1317809 crossref_primary_10_1007_s00535_024_02183_y crossref_primary_10_1007_s12088_024_01433_0 crossref_primary_10_3390_diagnostics13182960 crossref_primary_10_1053_j_gastro_2024_01_049 crossref_primary_10_1016_j_mib_2021_04_004 crossref_primary_10_1111_liv_15160 crossref_primary_10_1097_MEG_0000000000002666 crossref_primary_10_1097_MOG_0000000000000809 crossref_primary_10_1097_MOG_0000000000000807 crossref_primary_10_7554_eLife_99282_3 crossref_primary_10_1097_CM9_0000000000002291 crossref_primary_10_1007_s00281_022_00936_6 crossref_primary_10_3748_wjg_v31_i10_101014 crossref_primary_10_5009_gnl220537 crossref_primary_10_1186_s40168_023_01735_3 crossref_primary_10_1007_s00535_020_01740_5 crossref_primary_10_1016_j_autrev_2023_103486 crossref_primary_10_1136_rmdopen_2023_003529 crossref_primary_10_3390_microorganisms10020312 crossref_primary_10_1186_s40168_023_01698_5 crossref_primary_10_1002_imt2_241 crossref_primary_10_1016_j_jhep_2023_09_031 crossref_primary_10_3389_fcell_2020_631460 crossref_primary_10_1016_j_jbspin_2021_105245 crossref_primary_10_3389_fphys_2021_715852 crossref_primary_10_1136_gutjnl_2020_323565 crossref_primary_10_3389_fmed_2022_868812 crossref_primary_10_1128_spectrum_01324_22 crossref_primary_10_1016_j_scitotenv_2023_167530 crossref_primary_10_3389_fcimb_2024_1366192 crossref_primary_10_1093_nutrit_nuaf001 crossref_primary_10_3390_nu13031018 crossref_primary_10_1016_j_jcmgh_2023_12_005 crossref_primary_10_1152_physrev_00004_2023 crossref_primary_10_1093_ibd_izab343 crossref_primary_10_1158_2159_8290_CD_20_0304 crossref_primary_10_1002_imt2_105 crossref_primary_10_1007_s12072_020_10118_x crossref_primary_10_1038_s41575_023_00771_6 crossref_primary_10_1186_s12866_024_03663_0 crossref_primary_10_1080_29933935_2024_2400071 crossref_primary_10_3390_metabo14010023 crossref_primary_10_1136_gutjnl_2019_320008 crossref_primary_10_3748_wjg_v27_i33_5488 crossref_primary_10_1093_mmy_myad071 crossref_primary_10_1002_wsbm_1611 crossref_primary_10_1371_journal_ppat_1012377 crossref_primary_10_1002_hep_31140 crossref_primary_10_1002_jcp_30272 crossref_primary_10_1007_s00281_022_00917_9 crossref_primary_10_1186_s40168_021_01024_x crossref_primary_10_14309_ajg_0000000000000604 crossref_primary_10_1038_s41423_020_00592_6 crossref_primary_10_1159_000538493 crossref_primary_10_1186_s40168_023_01468_3 crossref_primary_10_1016_j_jhep_2021_11_029 crossref_primary_10_1128_msystems_01277_20 crossref_primary_10_1002_oby_23073 crossref_primary_10_1038_s41385_022_00515_w crossref_primary_10_1111_apt_15434 crossref_primary_10_23736_S2724_5985_21_02860_9 crossref_primary_10_1186_s40168_023_01586_y crossref_primary_10_3390_medicina60101713 crossref_primary_10_3390_microorganisms8122018 crossref_primary_10_4251_wjgo_v16_i4_1319 crossref_primary_10_3748_wjg_v28_i44_6213 |
Cites_doi | 10.1136/gutjnl-2016-313332 10.1016/S0140-6736(13)60096-3 10.1053/j.gastro.2013.12.030 10.1097/MOG.0000000000000052 10.1016/S0025-6196(11)64614-4 10.1038/srep19076 10.1016/j.jhep.2009.01.023 10.1053/j.gastro.2012.06.031 10.1136/gutjnl-2016-312533 10.1172/JCI90562 10.1099/jmm.0.008706-0 10.1136/gutjnl-2015-310500 10.1093/bioinformatics/btr507 10.1016/j.jhep.2009.04.009 10.1186/gb-2012-13-9-r79 10.1038/nmeth.f.303 10.1002/hep.26565 10.1111/apt.13552 10.1093/bioinformatics/btr026 10.1038/npjbiofilms.2016.9 10.1099/jmm.0.002188-0 10.3748/wjg.v23.i25.4548 10.3390/nu10080988 10.1177/2050640617708953 10.1128/AEM.02766-16 10.1016/j.clim.2016.10.006 10.1093/ecco-jcc/jju023 10.1016/j.steroids.2015.12.015 10.1046/j.1365-2249.2003.02166.x 10.1111/mec.12481 10.1053/j.gastro.2017.02.038 10.1073/pnas.0804812105 10.1093/cid/cix948 10.1111/jgh.14129 10.1136/gutjnl-2016-311915 10.1136/gutjnl-2016-312180 10.1056/NEJMra020831 10.3748/wjg.v24.i23.2468 10.1038/s41598-018-23870-w 10.1136/gutjnl-2016-313170 10.1186/1471-230X-13-175 10.1093/ecco-jcc/jjv204 10.1136/gutjnl-2015-311004 10.1002/ibd.20903 10.1136/gutjnl-2015-310746 10.1038/srep08096 10.1136/gutjnl-2016-313432 10.1016/j.jhep.2017.07.022 10.4065/75.7.688 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. 2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
CorporateAuthor | Saint-Antoine IBD Network |
CorporateAuthor_xml | – name: Saint-Antoine IBD Network |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 1XC VOOES |
DOI | 10.1136/gutjnl-2018-317791 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Sciences Collection BMJ Journals ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3288 |
EndPage | 102 |
ExternalDocumentID | oai_HAL_hal_02116096v1 31003979 10_1136_gutjnl_2018_317791 gutjnl |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | France United States--US |
GeographicLocations_xml | – name: United States--US – name: France |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 18M 29I 2WC 354 39C 3O- 4.4 40O 53G 5GY 5VS 7X7 7~S 88E 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAUVZ AAWJN AAYEP ABAAH ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AI. AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 DWQXO E3Z EBS EJD F5P FD8 FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR INH INR IOF ITC J5H KQ8 L7B LK8 M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VH1 VM9 VVN W8F WH7 WOQ X7M YFH YOC YQY ZGI ZXP ZY1 AAYXX ACQHZ ADGHP AERUA CITATION PHGZM CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 1XC PUEGO VOOES |
ID | FETCH-LOGICAL-b447t-c02cc776d82cbb29958310c16265b22e6469fa91927bad52c91ecf63d8f95eaa3 |
IEDL.DBID | 7X7 |
ISSN | 0017-5749 1468-3288 |
IngestDate | Tue Aug 26 06:21:14 EDT 2025 Mon Jul 21 10:51:20 EDT 2025 Fri Jul 25 09:14:34 EDT 2025 Mon Jul 21 05:47:37 EDT 2025 Tue Jul 01 02:49:07 EDT 2025 Thu Apr 24 23:03:07 EDT 2025 Thu Apr 24 22:53:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | fungi gut microbiota inflammatory bowel disease primary sclerosing cholangitis |
Language | English |
License | Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b447t-c02cc776d82cbb29958310c16265b22e6469fa91927bad52c91ecf63d8f95eaa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6469-0651 0000-0002-2914-1822 |
OpenAccessLink | https://hal.sorbonne-universite.fr/hal-02116096 |
PMID | 31003979 |
PQID | 2348225561 |
PQPubID | 2041069 |
PageCount | 11 |
ParticipantIDs | hal_primary_oai_HAL_hal_02116096v1 proquest_miscellaneous_2211949627 proquest_journals_2348225561 pubmed_primary_31003979 crossref_citationtrail_10_1136_gutjnl_2018_317791 crossref_primary_10_1136_gutjnl_2018_317791 bmj_primary_10_1136_gutjnl_2018_317791 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Gut |
PublicationTitleAlternate | Gut |
PublicationYear | 2020 |
Publisher | BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Iwasawa, Suda, Tsunoda 2017; 66 Morgan, Tickle, Sokol 2012; 13 Kollerov, Lobastova, Monti 2016; 107 Rühlemann, Heinsen, Zenouzi 2017; 66 Hirschfield, Karlsen, Lindor 2013; 382 Kevans, Tyler, Holm 2016; 10 Kummen, Holm, Anmarkrud 2017; 66 Quraishi, Sergeant, Kay 2017; 66 Muratori, Muratori, Guidi 2003; 132 Bajer, Kverka, Kostovcik 2017; 23 Weismüller, Trivedi, Bergquist 2017; 152 Hong, Kim, Jang 2009; 58 Henriksen, Melum, Karlsen 2014; 30 Vrieze, Van Nood, Holleman 2012; 143 Vasquez, Zavasky, Chow 2018; 66 Bajaj, Liu, Kheradman 2018; 67 Schmieder, Edwards 2011; 27 Sabino, Vieira-Silva, Machiels 2016; 65 Hiippala, Jouhten, Ronkainen 2018; 10 Karlsen, Folseraas, Thorburn 2017; 67 Sokol, Seksik, Furet 2009; 15 Magoč, Salzberg 2011; 27 Sokol, Pigneur, Watterlot 2008; 105 Podolsky 2002; 347 Chen, Liu, Zhou 2016; 6 Jiang, Wu, Wang 2015; 5 Yang, Inamine, Hochrath 2017; 127 Van den Bossche, Hindryckx, Devisscher 2017; 83 Li, Shen, Ran 2017; 175 2009; 51 Ye, Li, Wu 2018; 24 Wei, Yan, Zou 2013; 13 Torres, Bao, Goel 2016; 43 Caporaso, Kuczynski, Stombaugh 2010; 7 Tang, Wei, Li 2018; 67 Rudolph, Gotthardt, Klöters-Plachky 2009; 51 Iwasawa, Suda, Tsunoda 2018; 8 Grander, Adolph, Wieser 2018; 67 Udayappan, Manneras-Holm, Chaplin-Scott 2016; 2 Rossen, Fuentes, Boonstra 2015; 9 Torres, Palmela, Brito 2018; 6 Kõljalg, Nilsson, Abarenkov 2013; 22 Hirano, Umeno, Okamoto 2018 Boonstra, Weersma, van Erpecum 2013; 58 Corpechot, Gaouar, El Naggar 2014; 146 Sokol, Leducq, Aschard 2017; 66 Oztas, Odemis, Kekilli 2009; 58 Kim, Therneau, Wiesner 2000; 75 Hiippala (2020050721383096000_69.1.92.36) 2018; 10 Weismüller (2020050721383096000_69.1.92.3) 2017; 152 Karlsen (2020050721383096000_69.1.92.6) 2017; 67 Udayappan (2020050721383096000_69.1.92.39) 2016; 2 Ye (2020050721383096000_69.1.92.38) 2018; 24 2020050721383096000_69.1.92.1 2020050721383096000_69.1.92.40 2020050721383096000_69.1.92.8 2020050721383096000_69.1.92.11 2020050721383096000_69.1.92.33 Kollerov (2020050721383096000_69.1.92.41) 2016; 107 2020050721383096000_69.1.92.9 2020050721383096000_69.1.92.12 2020050721383096000_69.1.92.34 2020050721383096000_69.1.92.31 2020050721383096000_69.1.92.10 2020050721383096000_69.1.92.32 2020050721383096000_69.1.92.15 2020050721383096000_69.1.92.37 2020050721383096000_69.1.92.5 2020050721383096000_69.1.92.16 2020050721383096000_69.1.92.2 2020050721383096000_69.1.92.13 2020050721383096000_69.1.92.35 Iwasawa (2020050721383096000_69.1.92.47) 2018; 8 2020050721383096000_69.1.92.14 2020050721383096000_69.1.92.18 Podolsky (2020050721383096000_69.1.92.7) 2002; 347 Li (2020050721383096000_69.1.92.4) 2017; 175 Torres (2020050721383096000_69.1.92.19) 2018; 6 Vasquez (2020050721383096000_69.1.92.44) 2018; 66 2020050721383096000_69.1.92.30 2020050721383096000_69.1.92.22 2020050721383096000_69.1.92.23 2020050721383096000_69.1.92.45 2020050721383096000_69.1.92.20 2020050721383096000_69.1.92.42 2020050721383096000_69.1.92.21 2020050721383096000_69.1.92.43 2020050721383096000_69.1.92.26 2020050721383096000_69.1.92.48 2020050721383096000_69.1.92.27 2020050721383096000_69.1.92.46 2020050721383096000_69.1.92.25 Quraishi (2020050721383096000_69.1.92.17) 2017; 66 2020050721383096000_69.1.92.28 2020050721383096000_69.1.92.29 Rudolph (2020050721383096000_69.1.92.24) 2009; 51 31653787 - Gut. 2020 Oct;69(10):1890-1892 |
References_xml | – volume: 67 start-page: 534 year: 2018 article-title: Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy publication-title: Gut doi: 10.1136/gutjnl-2016-313332 – volume: 382 start-page: 1587 year: 2013 article-title: Primary sclerosing cholangitis publication-title: Lancet doi: 10.1016/S0140-6736(13)60096-3 – volume: 146 start-page: 970 year: 2014 article-title: Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.12.030 – volume: 30 start-page: 310 year: 2014 article-title: Update on primary sclerosing cholangitis genetics publication-title: Curr Opin Gastroenterol doi: 10.1097/MOG.0000000000000052 – volume: 75 start-page: 688 year: 2000 article-title: A revised natural history model for primary sclerosing cholangitis publication-title: Mayo Clin Proc doi: 10.1016/S0025-6196(11)64614-4 – volume: 6 start-page: 19076 year: 2016 article-title: Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults publication-title: Sci Rep doi: 10.1038/srep19076 – volume: 51 start-page: 149 year: 2009 article-title: Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis publication-title: J Hepatol doi: 10.1016/j.jhep.2009.01.023 – volume: 143 start-page: 913 year: 2012 article-title: Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.06.031 – volume: 66 start-page: 1344 year: 2017 article-title: Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis publication-title: Gut doi: 10.1136/gutjnl-2016-312533 – volume: 127 start-page: 2829 year: 2017 article-title: Intestinal fungi contribute to development of alcoholic liver disease publication-title: J Clin Invest doi: 10.1172/JCI90562 – volume: 58 start-page: 1243 year: 2009 article-title: Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis publication-title: J Med Microbiol doi: 10.1099/jmm.0.008706-0 – volume: 66 start-page: 611 year: 2017 article-title: The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls publication-title: Gut doi: 10.1136/gutjnl-2015-310500 – volume: 27 start-page: 2957 year: 2011 article-title: FLASH: fast length adjustment of short reads to improve genome assemblies publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr507 – volume: 51 start-page: 237 year: 2009 article-title: EASL Clinical Practice Guidelines: management of cholestatic liver diseases publication-title: J Hepatol doi: 10.1016/j.jhep.2009.04.009 – volume: 13 start-page: R79 year: 2012 article-title: Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment publication-title: Genome Biol doi: 10.1186/gb-2012-13-9-r79 – volume: 7 start-page: 335 year: 2010 article-title: QIIME allows analysis of high-throughput community sequencing data publication-title: Nat Methods doi: 10.1038/nmeth.f.303 – volume: 58 start-page: 2045 year: 2013 article-title: Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis publication-title: Hepatology doi: 10.1002/hep.26565 – volume: 43 start-page: 790 year: 2016 article-title: The features of mucosa-associated microbiota in primary sclerosing cholangitis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13552 – volume: 27 start-page: 863 year: 2011 article-title: Quality control and preprocessing of metagenomic datasets publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr026 – volume: 2 start-page: 16009 year: 2016 article-title: Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice publication-title: NPJ Biofilms Microbiomes doi: 10.1038/npjbiofilms.2016.9 – volume: 58 start-page: 674 year: 2009 article-title: Liver cirrhosis caused by Exophiala dermatitidis publication-title: J Med Microbiol doi: 10.1099/jmm.0.002188-0 – volume: 23 start-page: 4548 year: 2017 article-title: Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v23.i25.4548 – volume: 10 start-page: 988 year: 2018 article-title: The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation publication-title: Nutrients doi: 10.3390/nu10080988 – volume: 6 start-page: 112 year: 2018 article-title: The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease publication-title: United European Gastroenterol J doi: 10.1177/2050640617708953 – volume: 83 year: 2017 article-title: Ursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice publication-title: Appl Environ Microbiol doi: 10.1128/AEM.02766-16 – volume: 175 start-page: 115 year: 2017 article-title: Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease publication-title: Clin Immunol doi: 10.1016/j.clim.2016.10.006 – volume: 9 start-page: 342 year: 2015 article-title: The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jju023 – volume: 107 start-page: 20 year: 2016 article-title: Deoxycholic acid transformations catalyzed by selected filamentous fungi publication-title: Steroids doi: 10.1016/j.steroids.2015.12.015 – volume: 132 start-page: 473 year: 2003 article-title: Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.2003.02166.x – volume: 22 start-page: 5271 year: 2013 article-title: Towards a unified paradigm for sequence-based identification of fungi publication-title: Mol Ecol doi: 10.1111/mec.12481 – volume: 152 start-page: 1975 year: 2017 article-title: Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.02.038 – volume: 105 start-page: 16731 year: 2008 article-title: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0804812105 – volume: 66 start-page: 959 year: 2018 article-title: Management of an outbreak of exophiala dermatitidis bloodstream infections at an outpatient oncology clinic publication-title: Clin Infect Dis doi: 10.1093/cid/cix948 – start-page: 1590 year: 2018 article-title: Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.14129 – volume: 66 start-page: 386.1 year: 2017 article-title: The gut-adherent microbiota of PSC-IBD is distinct to that of IBD publication-title: Gut doi: 10.1136/gutjnl-2016-311915 – volume: 66 start-page: 753 year: 2017 article-title: Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis publication-title: Gut doi: 10.1136/gutjnl-2016-312180 – volume: 347 start-page: 417 year: 2002 article-title: Inflammatory bowel disease. publication-title: N Engl J Med Overseas Ed doi: 10.1056/NEJMra020831 – volume: 24 start-page: 2468 year: 2018 article-title: Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i23.2468 – volume: 8 start-page: 5480 year: 2018 article-title: Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker publication-title: Sci Rep doi: 10.1038/s41598-018-23870-w – volume: 67 start-page: 1146 year: 2018 article-title: Fungal dysbiosis in cirrhosis publication-title: Gut doi: 10.1136/gutjnl-2016-313170 – volume: 13 start-page: 175 year: 2013 article-title: Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-13-175 – volume: 10 start-page: 330 year: 2016 article-title: Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jjv204 – volume: 65 start-page: 1681 year: 2016 article-title: Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD publication-title: Gut doi: 10.1136/gutjnl-2015-311004 – volume: 15 start-page: 1183 year: 2009 article-title: Low counts of Faecalibacterium prausnitzii in colitis microbiota publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20903 – volume: 66 start-page: 1039 year: 2017 article-title: Fungal microbiota dysbiosis in IBD publication-title: Gut doi: 10.1136/gutjnl-2015-310746 – volume: 5 start-page: 8096 year: 2015 article-title: Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease publication-title: Sci Rep doi: 10.1038/srep08096 – volume: 67 start-page: 891 year: 2018 article-title: Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease publication-title: Gut doi: 10.1136/gutjnl-2016-313432 – volume: 67 start-page: 1298 year: 2017 article-title: Primary sclerosing cholangitis - a comprehensive review publication-title: J Hepatol doi: 10.1016/j.jhep.2017.07.022 – volume: 24 start-page: 2468 year: 2018 ident: 2020050721383096000_69.1.92.38 article-title: Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i23.2468 – ident: 2020050721383096000_69.1.92.14 doi: 10.3748/wjg.v23.i25.4548 – ident: 2020050721383096000_69.1.92.11 doi: 10.1093/ecco-jcc/jjv204 – volume: 10 start-page: 988 year: 2018 ident: 2020050721383096000_69.1.92.36 article-title: The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation publication-title: Nutrients doi: 10.3390/nu10080988 – ident: 2020050721383096000_69.1.92.2 doi: 10.1016/S0140-6736(13)60096-3 – ident: 2020050721383096000_69.1.92.43 doi: 10.1136/gutjnl-2016-313332 – ident: 2020050721383096000_69.1.92.5 doi: 10.1097/MOG.0000000000000052 – ident: 2020050721383096000_69.1.92.21 doi: 10.1136/gutjnl-2016-313170 – ident: 2020050721383096000_69.1.92.16 doi: 10.1136/gutjnl-2015-310500 – ident: 2020050721383096000_69.1.92.34 doi: 10.1038/srep19076 – ident: 2020050721383096000_69.1.92.37 doi: 10.1111/jgh.14129 – ident: 2020050721383096000_69.1.92.18 doi: 10.1136/gutjnl-2016-312180 – volume: 66 start-page: 959 year: 2018 ident: 2020050721383096000_69.1.92.44 article-title: Management of an outbreak of exophiala dermatitidis bloodstream infections at an outpatient oncology clinic publication-title: Clin Infect Dis doi: 10.1093/cid/cix948 – volume: 8 start-page: 5480 year: 2018 ident: 2020050721383096000_69.1.92.47 article-title: Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker publication-title: Sci Rep doi: 10.1038/s41598-018-23870-w – ident: 2020050721383096000_69.1.92.28 doi: 10.1093/bioinformatics/btr507 – ident: 2020050721383096000_69.1.92.20 doi: 10.1172/JCI90562 – ident: 2020050721383096000_69.1.92.45 doi: 10.1099/jmm.0.008706-0 – volume: 66 start-page: 386.1 year: 2017 ident: 2020050721383096000_69.1.92.17 article-title: The gut-adherent microbiota of PSC-IBD is distinct to that of IBD publication-title: Gut doi: 10.1136/gutjnl-2016-311915 – ident: 2020050721383096000_69.1.92.22 doi: 10.1136/gutjnl-2015-310746 – volume: 51 start-page: 149 year: 2009 ident: 2020050721383096000_69.1.92.24 article-title: Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis publication-title: J Hepatol doi: 10.1016/j.jhep.2009.01.023 – volume: 175 start-page: 115 year: 2017 ident: 2020050721383096000_69.1.92.4 article-title: Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease publication-title: Clin Immunol doi: 10.1016/j.clim.2016.10.006 – volume: 2 start-page: 16009 year: 2016 ident: 2020050721383096000_69.1.92.39 article-title: Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice publication-title: NPJ Biofilms Microbiomes doi: 10.1038/npjbiofilms.2016.9 – ident: 2020050721383096000_69.1.92.29 doi: 10.1038/nmeth.f.303 – ident: 2020050721383096000_69.1.92.31 doi: 10.1186/gb-2012-13-9-r79 – ident: 2020050721383096000_69.1.92.33 doi: 10.1186/1471-230X-13-175 – ident: 2020050721383096000_69.1.92.10 doi: 10.1093/ecco-jcc/jju023 – ident: 2020050721383096000_69.1.92.26 doi: 10.1053/j.gastro.2013.12.030 – ident: 2020050721383096000_69.1.92.23 doi: 10.1046/j.1365-2249.2003.02166.x – volume: 6 start-page: 112 year: 2018 ident: 2020050721383096000_69.1.92.19 article-title: The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease publication-title: United European Gastroenterol J doi: 10.1177/2050640617708953 – ident: 2020050721383096000_69.1.92.35 doi: 10.1038/srep08096 – ident: 2020050721383096000_69.1.92.8 doi: 10.1073/pnas.0804812105 – ident: 2020050721383096000_69.1.92.40 doi: 10.1053/j.gastro.2012.06.031 – volume: 152 start-page: 1975 year: 2017 ident: 2020050721383096000_69.1.92.3 article-title: Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.02.038 – ident: 2020050721383096000_69.1.92.25 doi: 10.1016/j.jhep.2009.04.009 – ident: 2020050721383096000_69.1.92.46 doi: 10.1099/jmm.0.002188-0 – volume: 67 start-page: 1298 year: 2017 ident: 2020050721383096000_69.1.92.6 article-title: Primary sclerosing cholangitis - a comprehensive review publication-title: J Hepatol doi: 10.1016/j.jhep.2017.07.022 – ident: 2020050721383096000_69.1.92.42 doi: 10.1128/AEM.02766-16 – ident: 2020050721383096000_69.1.92.9 doi: 10.1002/ibd.20903 – ident: 2020050721383096000_69.1.92.48 doi: 10.1136/gutjnl-2016-313432 – ident: 2020050721383096000_69.1.92.13 doi: 10.1136/gutjnl-2015-311004 – ident: 2020050721383096000_69.1.92.1 doi: 10.1002/hep.26565 – ident: 2020050721383096000_69.1.92.15 doi: 10.1136/gutjnl-2016-312533 – ident: 2020050721383096000_69.1.92.30 doi: 10.1111/mec.12481 – ident: 2020050721383096000_69.1.92.12 doi: 10.1111/apt.13552 – ident: 2020050721383096000_69.1.92.27 doi: 10.1093/bioinformatics/btr026 – ident: 2020050721383096000_69.1.92.32 doi: 10.4065/75.7.688 – volume: 347 start-page: 417 year: 2002 ident: 2020050721383096000_69.1.92.7 article-title: Inflammatory bowel disease. publication-title: N Engl J Med Overseas Ed doi: 10.1056/NEJMra020831 – volume: 107 start-page: 20 year: 2016 ident: 2020050721383096000_69.1.92.41 article-title: Deoxycholic acid transformations catalyzed by selected filamentous fungi publication-title: Steroids doi: 10.1016/j.steroids.2015.12.015 – reference: 31653787 - Gut. 2020 Oct;69(10):1890-1892 |
SSID | ssj0008891 |
Score | 2.6382446 |
Snippet | ObjectivePatients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been... Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in... |
SourceID | hal proquest pubmed crossref bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 92 |
SubjectTerms | Adult Aged Authorship Bacteria Bacteria - classification Bacteria - isolation & purification Bacterial Typing Techniques - methods Biodiversity Cholangitis Cholangitis, Sclerosing - microbiology Deoxyribonucleic acid DNA Dysbacteriosis Dysbiosis - microbiology Endoscopy Female Fungi Fungi - classification Fungi - isolation & purification Gastroenterology Gastrointestinal Microbiome Genetic testing Gut microbiota Human health and pathology Humans Hépatology and Gastroenterology Inflammatory bowel disease Inflammatory Bowel Diseases - microbiology Intestinal microflora Library collections Life Sciences Liver diseases Male Microbiota Middle Aged Mycological Typing Techniques - methods Pathogenesis Young Adult |
Title | Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis |
URI | https://gut.bmj.com/content/69/1/92.full https://www.ncbi.nlm.nih.gov/pubmed/31003979 https://www.proquest.com/docview/2348225561 https://www.proquest.com/docview/2211949627 https://hal.sorbonne-universite.fr/hal-02116096 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA_eDcQXcX5enSOK-CJlN22TNE8yxy4XcUPEwX0LSZrMjq292t7B_nvPadOKDw6hT-1JE06-zu-c5HcIeVf4gltRqEQpAwAlz01iM7tIZFY464UJVuFF4dMzsTrPP6_5Ojrc2nisclwT-4W6bBz6yA9TZGFBviz2cfMzwaxRGF2NKTRmZBepyxB8yfUEuPAEDxtXYi5zNV6aycThxba7rK9gjDB0D8qeo3Nmry__2p5mP_Bw5L8sz34HWj4iD6PpSI-Gvt4j93z9mNw_jcHxJ6RcwsSt6MaMJ6U9rWoKBh4tb1tbNW3V0iZQaBO9rgb-pc6gSORWbSk6Zelm4J-gLVQCbYStjfYAGBMbVe1Tcr48-X68SmIShcTmuewSt0idk1KUReqshc2HY2oxxwDIcJumXgA-DkaBoSetKXnqFPMuiKwsguLemOwZ2amb2r8glFtp4Fm4YGRuC66sZMEGMBhZkKqUc_IeNKhjM3UPLzKhB1VrVLUeVD0nbFSydpGKHDNiXN1Z5sNU5n9qeAt9Nwkih_bq6IvGd2DUMAHA7QaE9seu1XHmtvrPOJuTN9NnmHMYSDG1b7Ygg7R4OaYtmpPnw5CYqsKACcZKX97981fkQYrIvXfm7JOd7tfWvwbzprMH_Rg-ILufTs6-fvsNS1b4jA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB51iwRcUHmVhRYMAi4o6ubhOD4gVAGrLd3tqZX2ZmzHgVRtspAsqH-K39iZvCoOVFwq5ZTYsTUej-flbwBeJy7hJk6kJ6VGAyWKtGdCM_FEmFjjYp0ZSReFF0fx7CT6suTLDfjT34WhtMpeJjaCOi0t-cj3AkJhIbws_8Pqh0dVoyi62pfQaNni0F38RpOten_wCdf3TRBMPx9_nHldVQHPRJGoPTsJrBUiTpPAGoPSmFOtLeujZs9NELgYDcZMS9R8hNEpD6z0nc3iME0yyZ3WIf53BLfw4J1QCqFYDgYeZQz5veTnIpL9JZ0w3vu2rk-LM-RJn9yRosEEHZnz07-Ow9F3Ssb8l6bbnHjTLbjXqapsv-Wt-7Dhigdwe9EF4x9COkVBkbOV7jOzHcsLhgolSy8qk5dVXrEyYzgndp63eE-1piYdlmvFyAnMVi3eBatwEJwjHqWsMbipkFJePYKTGyHvY9gsysI9AcaN0PhMbKZFZBIujfAzk6GC6mdCpmIMb5GCqpumasyZMFYtqRWRWrWkHoPfE1nZDvqcKnCcXdvn3dDnf0Z4hWs3NCTM7tn-XNE7VKL8GA3FX9hop19a1UmKSl3x9RheDp9xj1PgRheuXGMbguGLqEzSGLZblhiGogANxWafXv_zF3BndryYq_nB0eEzuBuQ16BxJO3AZv1z7XZRtarN84afGXy96Q10CbdNM7o |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB51i1RxQeW9pYBBwAVFu3k6PiBUUVZb-hAHKu3N2I4NqdpkS7Kt-tf665jJC3Gg4lJpT1kntsbjefsbgDepTWOdpMITQqGDEkXK06GeejxMjbaJclrQReHDo2R-HH1ZxIs1uO7vwlBZZS8TG0GdlYZi5JOAUFgIL8ufuK4s4uvu7OPy3KMOUpRp7dtptCyyb68u0X2rPuzt4l6_DYLZ52-f5l7XYcDTUcRrz0wDYzhPsjQwWqNkjqnvlvHRyo91ENgEnUenBFpBXKssDozwrXFJmKVOxFapEL87gjs8RLWJZ4kvBmePqof8XgvEPBL9hZ0wmfxY1SfFKfKnT6FJ3uCDjvTZyV-qcfSTCjP_ZfU22m-2Cfc6s5XttHx2H9Zs8QA2DrvE_EPIZig0crZUfZW2ZXnB0Lhk2VWl87LKK1Y6hmtiZ3mL_VQrGtLhulaMAsJs2WJfsAonwTWiWmWN801NlfLqERzfCnkfw3pRFvYpsFhzhb-pcYpHOo2F5r7TDo1V33GR8TG8QwrKbpmycW3CRLaklkRq2ZJ6DH5PZGk6GHTqxnF64zvvh3f-Z4bXuHfDQMLvnu8cSHqGBpWfoNN4gYO2-62VndSo5B8eH8Or4W8875TEUYUtVziGIPkiapk0hictSwxTUbKG8rRbN3_8JWzg0ZEHe0f7z-BuQAGEJqa0Dev1r5V9jlZWrV807Mzg-22fn98U6jfw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fungi+participate+in+the+dysbiosis+of+gut+microbiota+in+patients+with+primary+sclerosing+cholangitis&rft.jtitle=Gut&rft.au=Lemoinne%2C+Sara&rft.au=Kemgang%2C+Astrid&rft.au=Ben+Belkacem%2C+Karima&rft.au=Straube%2C+Marjol%C3%A8ne&rft.date=2020-01-01&rft.issn=1468-3288&rft.eissn=1468-3288&rft.volume=69&rft.issue=1&rft.spage=92&rft_id=info:doi/10.1136%2Fgutjnl-2018-317791&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon |